Most Popular
Bayer’s Groundbreaking Elinzanetant Secures Success in Third Phase III Study
A New Dawn for Bayer’s Elinzanetant Bayer AG BAYRY reported favorable top-line outcomes from the phase III trial, OASIS 3, evaluating the efficacy and ...
Uncovering EPR Properties’ Series E Preferred Shares and Their Mighty 8% Yield
An Eye on the Yield EPR Properties is making waves in the trading world as its 9.00% Series E Cumulative Convertible Preferred Shares (Symbol: ...
The Promise of Prosperity: Howmet Aerospace Inc. (HWM) Poised for Growth
Strength in Diversity Howmet Aerospace Inc., symbolized by HWM, stands firm in the face of challenges, benefiting from its diverse end markets, commitment to ...
Impressive Gains for PTC Therapeutics (PTCT) following Regulatory Success
Exciting Regulatory Progress for PTCT PTC Therapeutics, Inc. PTCT recently made waves in the pharmaceutical world with the submission of a biologics license application ...
BOTZ, TSDD: Big ETF Outflows
ETF Outflows Send Shockwaves Through BOTZ and TSDD Wave of ETF Outflows Hits BOTZ Within the realm of ETFs scrutinized by ETF Channel, a ...
Revolutionizing Transit Ads: OUTFRONT Media (OUT) Takes NYC by Storm
Revolutionizing Transit Ads: OUTFRONT Media (OUT) Takes NYC by Storm
In the pulsating heart of New York City, a revolution is underway. OUTFRONT Media Inc. OUT is shaking up the advertising landscape with its ...
General Mills Exceeds Expectations but Faces Declining Sales
General Mills, Inc. , the renowned titan of breakfast cereals, has unveiled its third-quarter fiscal 2024 report, showcasing figures that outperformed the Zacks Consensus ...
Fusion Pharmaceuticals Soars 99% After AstraZeneca’s $2.4B Acquisition Offer
Fusion Pharmaceuticals Soars 99% After AstraZeneca’s $2.4B Acquisition Offer
Fusion Pharmaceuticals FUSN recently inked a deal with AstraZeneca AZN, where AstraZeneca will acquire all outstanding shares of Fusion at $21 per share in ...
Walgreens Wins Exclusive Rights to Distribute VIVJOA Through AllianceRx Pharmacy
Walgreens Boots Alliance, Inc. WBA is paving its way to the forefront of the pharmaceutical industry with the recent exclusivity deal to distribute Mycovia ...
